| P2093 | author name string | Elisabeth Suri-Payer | |
| | Benedikt Fritzsching | |
| P2860 | cites work | Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function | Q24317859 |
| | Essential role for CD103 in the T cell-mediated regulation of experimental colitis | Q24646106 |
| | Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 | Q24672849 |
| | CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms | Q24673863 |
| | Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation | Q24676080 |
| | Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 |
| | Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 |
| | Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases | Q28131652 |
| | B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes | Q28143530 |
| | B cells and professional APCs recruit regulatory T cells via CCL4 | Q28204573 |
| | Where CD4+CD25+ T reg cells impinge on autoimmune diabetes | Q28506933 |
| | Regulatory T cell lineage specification by the forkhead transcription factor foxp3 | Q28510328 |
| | A function for interleukin 2 in Foxp3-expressing regulatory T cells | Q28590646 |
| | Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7 | Q28591451 |
| | Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor | Q28595009 |
| | Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival | Q29547865 |
| | An essential role for Scurfin in CD4+CD25+ T regulatory cells | Q29618395 |
| | Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease | Q30434096 |
| | Failure of CD25+ T cells from lupus-prone mice to suppress lupus glomerulonephritis and sialoadenitis | Q30437306 |
| | Neonatal autoimmune disease: influence of CD4+ CD25+ regulatory T cells | Q30437481 |
| | Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node | Q30438088 |
| | Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice | Q30498716 |
| | Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo | Q33723552 |
| | Regulatory T cells in autoimmmunity*. | Q33904108 |
| | Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion | Q33932451 |
| | Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter | Q33936032 |
| | Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. | Q34032006 |
| | Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance | Q34111451 |
| | CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor | Q34116317 |
| | Cutting edge: depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease | Q34132578 |
| | CD4+CD25+ regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity | Q34161141 |
| | Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells | Q34189120 |
| | Toll-like receptor 2 controls expansion and function of regulatory T cells | Q34264024 |
| | Role of LAG-3 in regulatory T cells. | Q34358935 |
| | Control of organ-specific autoimmunity by immunoregulatory CD4(+)CD25(+) T cells | Q34374577 |
| | Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells | Q34374601 |
| | Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism | Q34392100 |
| | Regulatory T cells in spontaneous autoimmune encephalomyelitis | Q34448458 |
| | Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance | Q34503328 |
| | Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. | Q34509694 |
| | Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance | Q34530668 |
| | Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide | Q34531452 |
| | CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis. | Q34533631 |
| | In vivo instruction of suppressor commitment in naive T cells | Q34548023 |
| | TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells | Q34556464 |
| | Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling | Q34561791 |
| | CD4+ CD25+ suppressor T cells: more questions than answers | Q34716304 |
| | In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro | Q35171080 |
| | TGF-beta: the perpetrator of immune suppression by regulatory T cells and suicidal T cells | Q35668744 |
| | CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice | Q35748975 |
| | Activated CD4+CD25+ T cells selectively kill B lymphocytes | Q35848308 |
| | Cure of innate intestinal immune pathology by CD4+CD25+ regulatory T cells | Q36064100 |
| | The role of self-peptides in the development of CD4+ CD25+ regulatory T cells | Q36070689 |
| | The NOD mouse: a model of immune dysregulation | Q36072434 |
| | Regulatory T cells and intestinal homeostasis | Q36079900 |
| | Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice. | Q36242785 |
| | Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation | Q36367099 |
| | Peripheral autoantigen induces regulatory T cells that prevent autoimmunity | Q36367859 |
| | CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness | Q36370807 |
| | Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node | Q36371218 |
| | Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo | Q36371283 |
| | Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. | Q36371658 |
| | Tr1 cells: from discovery to their clinical application. | Q36390028 |
| | Peripheral expansion of thymus-derived regulatory cells in anti-myelin basic protein T cell receptor transgenic mice. | Q51032566 |
| | Toll-dependent control mechanisms of CD4 T cell activation. | Q51996404 |
| | CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells. | Q52552727 |
| | Cutting edge: CD4+CD25+ regulatory T cells impaired for intestinal homing can prevent colitis. | Q53671891 |
| | Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. | Q53846430 |
| | Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. | Q53883439 |
| | CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. | Q54139898 |
| | Recovery from experimental allergic encephalomyelitis is TGF-beta dependent and associated with increases in CD4+LAP+ and CD4+CD25+ T cells. | Q54613578 |
| | CD4+CD25+ T cells prevent the development of organ-specific autoimmune disease by inhibiting the differentiation of autoreactive effector T cells. | Q54630443 |
| | TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation. | Q54641474 |
| | Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. | Q54656483 |
| | Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+CD25+ T cells | Q56902811 |
| | Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen | Q56902816 |
| | CD4+CD25+ Regulatory T Cells Cure Murine Colitis: The Role of IL-10, TGF-β, and CTLA4 | Q56903729 |
| | B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis | Q56905051 |
| | Human CD4+ T Cells Express TLR5 and Its Ligand Flagellin Enhances the Suppressive Capacity and Expression of FOXP3 in CD4+CD25+ T Regulatory Cells | Q57447880 |
| | Cutting Edge: TGF- Signaling Is Required for the In Vivo Expansion and Immunosuppressive Capacity of Regulatory CD4+CD25+ T Cells | Q58131166 |
| | Cooperation of Invariant NKT Cells and CD4+CD25+ T Regulatory Cells in the Prevention of Autoimmune Myasthenia | Q63363300 |
| | High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice | Q71641038 |
| | CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10 | Q73509865 |
| | Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4(+)CD25(+) T cells | Q73612987 |
| | Human CD4+ CD25+ regulatory T cells suppress NKT cell functions | Q73784466 |
| | Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells | Q74244102 |
| | The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7 | Q74650540 |
| | Blocking inducible co-stimulator in the absence of CD28 impairs Th1 and CD25+ regulatory T cells in murine colitis | Q75303091 |
| | IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells | Q75303125 |
| | Damage control, rather than unresponsiveness, effected by protective DX5+ T cells in autoimmune diabetes | Q77192908 |
| | Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo | Q77342616 |
| | Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals | Q77704341 |
| | Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis | Q78404404 |
| | T-cell compartments of prediabetic NOD mice | Q78830234 |
| | Cutting edge: IL-12 induces CD4+CD25- T cell activation in the presence of T regulatory cells | Q80345062 |
| | Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors | Q80444910 |
| | Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells | Q81245689 |
| | CD4+ CD25+ regulatory T cells inhibit the maturation but not the initiation of an autoantibody response | Q81245701 |
| | Inducing and expanding regulatory T cell populations by foreign antigen | Q81392563 |
| | MRL/Mp CD4+,CD25- T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus | Q81629357 |
| | A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection | Q81675748 |
| | Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis | Q82217105 |
| | CD4+CD25+ regulatory T cells inhibit the antigen-dependent expansion of self-reactive T cells in vivo | Q82310867 |
| | In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes | Q36399048 |
| | CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion | Q36399063 |
| | CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. | Q36399104 |
| | Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells | Q36399149 |
| | Essential role for interleukin-2 for CD4(+)CD25(+) T regulatory cell development during the neonatal period | Q36402733 |
| | T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells | Q36402737 |
| | Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization | Q36402763 |
| | Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis | Q36403300 |
| | Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes | Q36403481 |
| | CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner | Q36403637 |
| | TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes | Q37358159 |
| | Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis | Q37593413 |
| | LF 15-0195 treatment protects against central nervous system autoimmunity by favoring the development of Foxp3-expressing regulatory CD4 T cells. | Q38485693 |
| | Neuropilin-1: a surface marker of regulatory T cells | Q40584286 |
| | Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific | Q40910998 |
| | Post-thymectomy autoimmune gastritis: fine specificity and pathogenicity of anti-H/K ATPase-reactive T cells | Q40969391 |
| | Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells | Q41895496 |
| | Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo | Q42210265 |
| | Transforming growth factor beta induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis. | Q42844822 |
| | Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion | Q45864833 |
| | Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice | Q45883411 |
| | Cutting Edge: CD28 Controls Peripheral Homeostasis of CD4+CD25+ Regulatory T Cells | Q46025217 |
| | Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice | Q46081630 |
| | On the edge of autoimmunity: T-cell stimulation by steady-state dendritic cells prevents autoimmune diabetes | Q46818613 |
| | Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T cell compartment | Q47243986 |
| | CD7 and CD28 are required for murine CD4+CD25+ regulatory T cell homeostasis and prevention of thyroiditis | Q47283198 |
| | Colitis is associated with thymic destruction attenuating CD4+25+ regulatory T cells in the periphery | Q47368988 |
| | Colitogenic Th1 cells are present in the antigen-experienced T cell pool in normal mice: control by CD4+ regulatory T cells and IL-10. | Q47777664 |
| | Cutting edge: ligation of the glucocorticoid-induced TNF receptor enhances autoreactive CD4+ T cell activation and experimental autoimmune encephalomyelitis | Q47810532 |
| | Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells | Q47810559 |
| | Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells | Q47991866 |
| | Suppression of CD4+ T lymphocyte effector functions by CD4+CD25+ cells in vivo. | Q47992041 |
| | Demonstration of strong enterobacterial reactivity of CD4+CD25- T cells from conventional and germ-free mice which is counter-regulated by CD4+CD25+ T cells | Q48020872 |
| P433 | issue | 1 | |
| P921 | main subject | autoimmune disease | Q8084905 |
| P304 | page(s) | 3-16 | |
| P577 | publication date | 2006-07-13 | |
| P1433 | published in | Seminars in Immunopathology | Q15724576 |
| P1476 | title | Regulatory T cells in experimental autoimmune disease | |
| P478 | volume | 28 | |